Zura Bio Ltd (NASDAQ:ZURA) traded at $3.68 at last check on Wednesday, July 24, made a downward move of -4.17% on its previous day’s price.
Looking at the stock we see that its previous close was $3.84 . In terms of its 52-week price range, ZURA has a high of $7.63 and a low of $2.00. The company’s stock has gained about 8.88% over that past 30 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Zura Bio Ltd has a market cap of $234.60 million.
Based on estimates by 10 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 2 have rated the Zura Bio Ltd (ZURA) stock as a Hold, while 7 rate it as a Buy. 1 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 2.81% off its SMA20 and -12.74% from its 50-day simple moving average. The RSI (14) is pointing at 48.63 while the volatility over the past week is 7.56% and jumps to 8.49% over the past one month. The beta value is 0.16, while the average true range (ATR) is currently pointing at 0.31.
Coming back to Zura Bio Ltd (NASDAQ:ZURA), we note that the average 3-month trading volume was 253.51K, while that of the preceding 10-day period stands at 0.43 million. Current shares outstanding are 43.59 million.
The insiders hold 48.08% of the company’s shares while institutions hold 37.37%. The data shows that short shares as of 2024-06-28, stood at 0.71 million at a short ratio of 4.47. This represents a 1.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.61.6 short interest in shares outstanding on 2024-06-28. Shares short rose in June from the previous month at 0.57 million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -21.20% down in year-to-date price movement.
